Cassava’s Cognition Maintenance Study may prove Simufilam works

The FDA will approve less than perfect therapies if there is nothing useful for a serious condition. Consider the following from Proc. Natl. Acad. Sci. vol. 119 e2120512119 ’22 “KRAS is the most frequently mutated oncogene in human cancer, with mutations detected across many lineages, particularly in the pancreas, colon, and lungs. Among the most … Continue reading Cassava’s Cognition Maintenance Study may prove Simufilam works